Myriad Genetics First Quarter 2024 Financial Earnings

Tuesday, May 7, 2024 | 1:30pm PST / 4:30pm EST

Events & Presentations

  • 45th Annual Global Goldman Sachs Global Healthcare Conference

    06/12/2024 | 12:20pm PDT / 3:20pm EDT

  • Leerink Partners Healthcare Crossroads Conference

    05/30/2024 | 8:00am PDT / 11:00am EDT

  • Piper Sandler Virtual Cancer Testing Day

    05/21/2024 | 8:00am PDT / 11:00am EDT

Financial Reports and Filings

Date Filing Title Downloads
06/10/2024 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
06/07/2024 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
06/07/2024 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
06/07/2024 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
06/07/2024 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
06/07/2024 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
06/07/2024 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
06/07/2024 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
06/06/2024 8-K Report of unscheduled material events or corporate event RTF XLS PDF HTML XBRL
06/04/2024 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL

Latest News

Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 Countries Thumbnail

Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 Countries

Jun 11, 2024 | Products

Read more
Myriad Genetics Launches New Universal Plus Panel for Foresight® Carrier Screen Thumbnail

Myriad Genetics Launches New Universal Plus Panel for Foresight® Carrier Screen

Jun 04, 2024 | Products

Read more
Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool Thumbnail

Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool

Jun 03, 2024 | Products

Read more

Our commitment to social responsibility

At Myriad, social responsibility plays an important role in our approach to discovering and delivering valuable, transformative diagnostic tests across all major diseases to improve patients’ lives.

Learn more about the actions we’re taking in ESG

“As a leader in genetic testing and precision medicine, we understand the important role we play in advancing health equity and social justice. We also recognize our responsibility to operate in harmony with the environment which includes efforts to minimize our impact on the climate. These topics are directly linked with our purpose and values. We are proud to release our second annual environmental, social, and governance (ESG) report."

— Paul Diaz
President and CEO of Myriad Genetics

Our commitment to social responsibility

At Myriad, social responsibility plays an important role in our approach to discovering and delivering valuable, transformative diagnostic tests across all major diseases to improve patients’ lives.

Learn more about the actions we’re taking in ESG

“As a leader in genetic testing and precision medicine, we understand the important role we play in advancing health equity and social justice. We also recognize our responsibility to operate in harmony with the environment which includes efforts to minimize our impact on the climate. These topics are directly linked with our purpose and values. We are proud to release our second annual environmental, social, and governance (ESG) report."

— Paul Diaz
President and CEO of Myriad Genetics